Paper1979628
JO 1784, a potent and selective ligand for rat and mouse brain sigma-sites.
Roman FJ and 4 others. J Pharm Pharmacol, 1990. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. JO 1784, a potent and selective ligand for rat and mouse brain sigma-sites. Papers, record 1979628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1979628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Chemistry | Major topic |
| Cinnamates | Major topic |
| Cyclopropanes | Major topic |
| Receptors, Opioid | Major topic |
| Animals | |
| In Vitro Techniques | |
| Male | |
| Mice | |
| Phenazocine | |
| Phencyclidine | |
| Rats | |
| Rats, Inbred Strains | |
| Receptors, Opioid, delta |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41501471 | Electrochemical defluorinative Matteson-type homologation. | Nature | 2026 | https://conductscience.org/library/papers/41501471 | PubMed |
| 40965607 | Sigma-1 Receptor Ligands for CNS Cancer Treatment. | CNS Drugs | 2025 | https://conductscience.org/library/papers/40965607 | PubMed |
| 36419621 | Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36419621 | PubMed |
| 32992988 | Chaperone Sigma1R and Antidepressant Effect. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32992988 | PubMed |
| 32875386 | How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer. | Rev Physiol Biochem Pharmacol | 2021 | https://conductscience.org/library/papers/32875386 | PubMed |
| 31695608 | Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31695608 | PubMed |
| 28114279 | The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasis. | Oncogene | 2017 | https://conductscience.org/library/papers/28114279 | PubMed |
| 21680736 | Sig1R protein regulates hERG channel expression through a post-translational mechanism in leukemic cells. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21680736 | PubMed |
| 17068104 | The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. | J Physiol | 2007 | https://conductscience.org/library/papers/17068104 | PubMed |
| 15205309 | Attenuation by a sigma1 (sigma1) receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats. | Br J Pharmacol | 2004 | https://conductscience.org/library/papers/15205309 | PubMed |
| 15197533 | Sigma receptors: biology and therapeutic potential. | Psychopharmacology (Berl) | 2004 | https://conductscience.org/library/papers/15197533 | PubMed |
| 12235074 | Antidiarrhoeal properties of a novel sigma ligand (JO 2871) on toxigenic diarrhoea in mice: mechanisms of action. | Gut | 2002 | https://conductscience.org/library/papers/12235074 | PubMed |
| 11588125 | Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11588125 | PubMed |
| 10486366 | The sigma ligand, igmesine, inhibits cholera toxin and Escherichia coli enterotoxin induced jejunal secretion in the rat. | Gut | 1999 | https://conductscience.org/library/papers/10486366 | PubMed |
| 9084059 | Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors. | Psychopharmacology (Berl) | 1997 | https://conductscience.org/library/papers/9084059 | PubMed |
| 8935704 | Electrophysiological evidence for the implication of cholecystokinin in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus. | Naunyn Schmiedebergs Arch Pharmacol | 1996 | https://conductscience.org/library/papers/8935704 | PubMed |
| 8075892 | The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin. | Br J Pharmacol | 1994 | https://conductscience.org/library/papers/8075892 | PubMed |
| 7731982 | Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7731982 | PubMed |
| 7609778 | Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate. | Naunyn Schmiedebergs Arch Pharmacol | 1995 | https://conductscience.org/library/papers/7609778 | PubMed |
| 1652142 | Effects of sigma receptor ligands on schedule-controlled behavior of rats: relation to sigma and PCP receptor binding affinity. | Psychopharmacology (Berl) | 1991 | https://conductscience.org/library/papers/1652142 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1979628
GET https://conductscience.org/api/papers/v1/1979628/cited_by?page=2